Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative)
2 clinical trials · Condition
◉ Watch Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative)
| Record | Firm | Date |
|---|---|---|
| Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma (NCT00901147) | Singapore General Hospital | 2009-11-01 |
Track Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative) automatically
Every clearance here is in the API, with alerts when new ones post.